3 results
Approved WMORecruiting
Nemo Healthcare B.V. recently developed a new technique for monitoring the unborn baby. This technique is already widely used in unborn babies over 37 weeks of gestational age. The purpose of this study is to examine if that new technique is also…
Approved WMORecruiting
This study will evaluate the safety, tolerability, pharmacokinetics, and activity of XmAb24306 as a single agent (Phase Ia) or in combination with a checkpoint inhibitor targeting the PD-L1/PD-1 axis (Phase Ib) in patients with locally advanced or…
Approved WMOCompleted
To determine the workability of the non-invasive abdominal electrode patch for implementation in clinical practice.